扩散核磁共振 (MRI) 在脑干质瘤基因型鉴定中具有价值,可以通过对白质道进行定量测量
Xiong Xiao1, Ne Yang2, Guocan Gu1
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, 119#, Nan Si Huan Xi Lu, Fengtai District, Beijing, 100070, China.
European radiology
|November 5, 2023
概括
扩散MRI (dMRI) 通过预测H3K27M突变,有效地确定脑干质瘤 (BSG) 的基因型. 白质管道测量显著提高dMRI模型的性能,用于非侵入性BSG基因型检测.
科学领域:
- 神经成像是一种神经成像.
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
背景情况:
- 脑干质瘤 (BSG) 是一种侵袭性的儿科瘤.
- 准确的H3K27M突变基因定型对于BSG诊断和治疗至关重要.
- 目前的基因型定型方法可能具有侵入性.
研究的目的:
- 评估扩散MRI (dMRI) 对H3K27M在BSG中的基因定型的实用性.
- 开发和验证基于dMRI的模型,用于非侵入性BSG基因型预测.
主要方法:
- 一个BSG患者的初级队列接受了dMRI (b=0,1000,2000秒/mm2).
- 计算了扩散张力和曲解成像 (DTI/DKI) 度量,提取了组图特征和白质 (WM) 管道测量.
- 多变量逻辑回归和ROC分析被用来构建和测试dMRI衍生的基因型化模型,并将临床变量纳入名图.
主要成果:
- 纳入瘤组图特征和WM通道测量的dMRI模型实现了高诊断性能 (AUC=0.9311).
- 通过WM管道测量,显著提高了基因型准确性 (p < 0.05).
- 结合最好的dMRI模型和临床数据的nomogram在初级 (AUC=0.9321) 和验证 (AUC=0.8951) 队列中表现出强的表现.
结论:
- 在BSG中,dMRI是用于非侵入性H3K27M基因型鉴定的一个有价值的工具.
- 在提高基于dMRI的BSG基因定型准确性方面,WM通道测量特别有效.
- 综合的dMRI和临床数据模型可以帮助BSG患者的临床决策.
相关概念视频
Assessment of Diffusion and Perfusion
Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...


